Nanfang Hospital Receives 2019 Clinical PDT Research Excellence Award at the 17th World Congress of the International Photodynamic Association in Boston Print E-mail
Thursday, 11 July 2019 10:18

Boston, USA, July 11, 2019 (GLOBE NEWSWIRE)

Boston, USA, July 11, 2019 (GLOBE NEWSWIRE) --

At the 17th International Photodynamic Association World Congress in Boston, Massachusetts, the Dermatology and Venerology Department of Nanfang Hospital, Guangzhou, Guangdong, China, was recognized with the 2019 Clinical PDT Research Excellence Award.

The Dermatology and Venerology Department of Nanfang Hospital, Southern Medical University, Guangzhou, is one of the most influential teams focusing on photodynamic therapy (PDT) in China. Under Professor Yanhua Liang, the Chief Physician of the Department of Dermatology, the Nanfang Hospital team has successfully treated over 2,000 patients with PDT since 2015 for indications including: condyloma acuminate, port-wine stain, Bowen’s disease, chromoblastomycosis, and verrucous epidermal. The Dermatology and Venerology Department of Nanfang Hospital team includes: Kang Zeng, Lifen Jiang, Sijin He, Hui Liu, Junpeng Li, Qian Li, Pingjiao Chen, Jia Guo, Menghua Zhu, Liang Huang, Xuebiao Peng, Liuping Liang, Li, Nasha Yu, Zaigao Zhou, Haimei Lan, Zhili Hu, JiaJia Xie, Xiaowen Huang, Jingying Wang, Xingyao Zheng, Meinian Xu, Chunping Ao, Sujia Wang and Li Wang.

IPA World Congress

The Boston World Congress was the 17th conference held by the International Photodynamic Association, marking 34 years of this global meeting. The IPA World Congresses, held every two years, are the leading PDT meetings bringing together members of the global photodynamic community to advance scientific and clinical research relating to photodiagnosis and photodynamic therapies. The Boston World Congress was led by Congress Chair and IPA President Dr. Tayyaba Hasan, Professor of Dermatology at the Wellman Center for Photomedicine, Harvard Medical School (HMS) and a Professor of Health Sciences and Technology (Harvard-MIT) and had record attendance with representatives from 33 countries.  The 2021 IPA World Congress will be hosted in Moscow, Russia and the 2023 IPA World Congress will be held in Shanghai, China.

About Photodynamic Therapy

Photodynamic Therapy (PDT) is a combination therapy involving light activated photosensitizers to diagnose and treat various types and stages of cancers and pre-cancers, macular degeneration and multidrug-resistant infections involving bacteria, viruses and fungi. First developed in the 1980s, PDT has demonstrated superior patient outcomes with considerable cost savings. Over the past 30 years, millions of patients globally have been successfully treated with PDT.

About the International Photodynamic Association

The International Photodynamic Association (IPA) was founded in 1986 to support and endorse the scientific advancement and clinical development of photodynamic therapy and photodiagnosis. With members and associates from over 30 countries, the IPA represents a truly global community consisting of prominent international scientists, clinicians and translational researchers, healthcare professionals and students across academic, hospital, government and private sector organizations. The IPA promotes the study of diagnosis and treatment using light-activated photosensitizers and disseminates scientific information to its members, the research community, and to the community at large. The IPA organizes a biennial World Congress around the world, providing members and non-members a unique opportunity to share and learn more about global developments relating specifically to photodynamic therapy and photodiagnosis. 

For further information: [email protected]

Angelika Vance  International Photodynamic Association  6048382702  [email protected]  

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!